Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|August 22, 2024
Clinical and molecular insights into cardiovascular disease in psoriatic patients and the potential protective role of apremilastNuria Barbarroja, Clementina López-Medina, Alejandro Escudero-Contreras, et al.
Reumatologia Clinica|November 15, 2011
[Efficacy and safety of abatacept in patients with rheumatoid arthritis and no prior treatment with biologics]Alejandro Escudero Contreras, M Carmen Castro-Villegas, M Vanesa Hernández-Hernández, et al.
Reumatologia Clinica|March 16, 2012
[How to optimize the antiTNF alpha therapy in spondylitis?]Maria del Carmen Castro Villegas, Alejandro Escudero Contreras, Maria Dolores Miranda García, et al.
The Journal of Rheumatology|February 13, 2002
The potential of ESSG spondyloarthropathy classification criteria as a diagnostic aid in rheumatological practiceElisa Muñoz Gomariz, MazoAgustínCisnal del, Verónica Pérez Guijo, et al.
International Journal of Behavioral Medicine|February 27, 2016
Upswings in Cheerful Mood and Disease Activity in Patients with Rheumatoid ArthritisCarlos Jesús Delgado-Domínguez, Alejandro Escudero-Contreras, Pilar Font-Ugalde, et al.
Seminars in Arthritis and Rheumatism|July 1, 2021
Which factors explain the patient global assessment in patients with ankylosing spondylitis? A hierarchical cluster analysis on REGISPONSER-ASClementina López-Medina, Lourdes Ladehesa-Pineda, M Ángeles Puche-Larrubia, et al.
Rheumatology (Oxford, England)|February 6, 2024
New advances in genomics and epigenetics in antiphospholipid syndromeChary López-Pedrera, Tomás Cerdó, Elizabeth C Jury, et al.
Reumatologia Clinica|July 29, 2011
[Chondrocalcinosis and hypomagnesemia: clinical and radiological progression]José González Domínguez, Alejandro Escudero Contreras, Verónica Pérez Guijo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 16, 2019
Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label TrialRaimon Sanmarti, Douglas J Veale, Emilio Martin-Mola, et al.
International Journal of Molecular Sciences|December 2, 2020
Effects of Biological Therapies on Molecular Features of Rheumatoid ArthritisChary Lopez-Pedrera, Nuria Barbarroja, Alejandra M Patiño-Trives, et al.
Pageof 8